Stock Quote

Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges more than 70% after some really bad news

Less than four months after going public and being valued at more than $3 billion by Wall Street, Zymergen Inc. unleashed some bad news Tuesday afternoon and was on pace to lose more than two-thirds of its market cap.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.